At the 17th edition (EMUC25), leading experts in medical oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology examined current practices, identified best therapies, and reviewed emerging innovations in genito-urinary (GU) cancers treatment and management.

From 13 to 16 November 2025, attendees received essential GU cancers updates, engaged in the popular hands-on training courses, and joined eye-opening multidisciplinary case discussions.

ecancer livestreamed sessions on bladder and prostate, see below.